key: cord-0973584-kxbls0kw
authors: Bailey, Kristina L.; Samuelson, Derrick R.; Wyatt, Todd A.
title: Alcohol Use Disorder: A Pre-existing Condition for COVID-19?
date: 2020-10-18
journal: Alcohol
DOI: 10.1016/j.alcohol.2020.10.003
sha: 90e3cdd7462608b078e049f4a6f37f6353839a88
doc_id: 973584
cord_uid: kxbls0kw

Alcohol misuse is long established as a contributor to the pathophysiology of the lung. The intersection of multi-organ responses to alcohol-mediated tissue injury likely contributes to the modulation of lung in response to injury. Indeed, the negative impact of alcohol on susceptibility to infection and on lung barrier function is now well documented. Thus, the alcohol lung represents a very likely comorbidity for the negative consequences of both COVID-19 susceptibility and severity. In this review, we present the known alcohol misuse ramifications on the lung in the context of the current coronavirus pandemic.

The coronavirus disease 2019 has become a pandemic with over 34 million people infected worldwide and more than 1 millions deaths at the time of this writing (https://coronavirus.jhu.edu). COVID-19, caused by the betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spread through respiratory droplets. The most common symptoms of COVID-19 are fever, dry cough, dyspnea and fatigue, although asymptomatic infections are widely recognized as well (Ren et al., 2020) . Other than those individuals with a pre-existing condition, morbidity and mortality appears to be greatest in men, older persons, and, in some reports, cigarette smokers (Grasselli et al., 2020; Wu & McGoogan, 2020) . The pathogenesis of SARS-CoV-2 infection can be described in two phases: in the first phase, an initial innate defense occurs in an attempt to provide lung defense. This is followed by a subsequent second phase of inflammation-associated tissue injury. In susceptible people, SARS-CoV-2 infection can progress to severe viral pneumonia and can lead to acute respiratory distress syndrome (ARDS). ARDS is a severe, diffuse inflammatory lung injury that often requires mechanical ventilation. In response to such a "cytokine storm," uncontrolled hyper-inflammation can result in multi-organ failure.

Very little is known about how heavy alcohol intake might influence COVID-19 infection.

While less than 15% of consumed alcohol enters the lung, exhalation is nonetheless a significant process for alcohol excretion as evidenced by the common use of the Breathalyzer Test to reliably estimate blood alcohol levels (Borkenstein & Smith, 1961) .

Heavy alcohol intake profoundly changes pulmonary innate and adaptive immunity, leading to higher rates of viral pneumonia (de Roux et al., 2006) , influenza A infection J o u r n a l P r e -p r o o f (Greenbaum et al., 2014) , respiratory syncytial virus (RSV) infection (Jerrells et al., 2007; Wyatt et al., 2019) , and bacterial pneumonia (Cappa & Coleman, 1923; Fernández-Solá et al., 1995; Saitz, Ghali, & Moskowitz, 1997) . In the 1918 influenza pandemic, heavy alcohol intake was recognized as a risk factor for poor outcomes (Oxford, 2000) . Many recent publications describing COVID-19 patients failed to include alcohol use history (Bhatraju et al., 2020; Wu & McGoogan, 2020) . Further complicating this omission is the need to make distinctions between those effects that are seen in the acute setting of intoxication versus those that would be expected from chronic, longstanding alcohol exposure.

Over half of the population surveyed in China reported increases in depression, anxiety, or stress in response to COVID-19 (Wang et al., 2020) . During social isolation, alcohol use disorders (AUDs) increased in Hubei province compared to other provinces in China due to COVID-19 outbreak (Ahmed et al., 2020) . Hubei experienced a 10-fold increase in hazardous drinking compared to other provinces with fewer restrictions (Ahmed et al., 2020) . In the United States, late April 2020 alcohol sales exhibited a 477% increase in sales compared to the same week in April 2019 (Nielsen Retail Measurement Services, 2020) . Social isolation and loneliness have long been recognized as a predisposing factor for problem drinking (Allen, Peterson, & Whipple, 1981) . Depending upon local economic conditions during the COVID-19 pandemic, people may initially consume less alcohol due to financial constraints, but eventually increase alcohol use as a consequence of elevated stress over time (Rehm et al., 2020) .

Alcohol intake has been implicated in at least one COVID-19 outbreak (Mungmungpuntipantip & Wiwanitkit, 2020) . In Thailand, 15 people in their twenties gathered for a farewell party. Eleven of them drank alcohol out of a single glass and all developed COVID-19 within a week. Four other individuals at the party who did not drink did not develop the illness. Other large gatherings involving heavy alcohol intake such as Mardi Gras in Louisiana also may have led to outbreaks and accelerated spread of the disease (Schuchat, 2020) .

Another way alcohol can encourage infection is through myths that drinking alcohol can protect against COVID-19 infection. A myth was propagated in Iran that gargling or drinking alcoholic beverages would disinfect the mouth or inside of the body and prevent infection by killing the virus. Because alcohol production is not legal in Iran, it is typically obtained through the black market. At least 180 people in Iran died drinking black market alcohol that was contaminated with methanol, with over 2,500 seeking medical care (Delirrad & Mohammadi, 2020) . The myth that alcohol prevents COVID-19 infection prompted the World Health Organization (World Health Organization) and the National Institute on Alcohol and Alcoholism (National Institute on Alcohol Abuse and Alcoholism) to release statements that heavy alcohol intake does not prevent COVID-

The ongoing pandemic is increasing hazardous drinking behaviors in a variety of ways.

In spite of a recent report that heavy alcohol intake is not associated with COVID-19 hospitalization in the United Kingdom (Hamer, Kivimäki, Gale, & Batty, 2020) , there are J o u r n a l P r e -p r o o f numerous ways in which alcohol misuse should be problematic in the context of COVID-19 infection (Testino, 2020) . Alcohol has a negative impact on lung innate defense and response to injury (S. M. Yeligar & Wyatt, 2019) . It has long been known that alcohol impairs the ability of the lung to fight infection (S. M. . The lung is exposed to more than 11,000 liters of air per day, based on average minute ventilation.

This air contains viral particles, bacterial components such as lipopolysaccharide, dust, particulate matter, and pollutants. The healthy lung utilizes a complex system to protect itself from such environmental toxicants involving physical barriers such as cough and mucociliary clearance to help rid itself of these pathogens and pollutants. Once the mechanical barriers are breached, lung immune effector substances and cells exist to accomplish clearance. Heavy alcohol intake can have a detrimental effect on each of these protective mechanisms, making it likely that substantial and long-term alcohol intake contributes to poor outcomes with COVID-19. We will review each of these mechanisms in turn.

A hallmark symptom of COVID-19 infection is dyspnea, or shortness of breath. Alcohol is already associated in some circumstances with dyspnea (Cardet et al., 2014) , thus suggesting the risk for increased dyspnea in the AUD patient with COVID-19. Because exhalation of alcohol is the primary route of lung excretion, diminished removal of alcohol from the lungs of a COVID-19 infected individual could potentially result in increased exposure to direct alcohol impairment of lung innate defenses or elevated production of alcohol metabolites in lung injury.

Although alcohol is long known to suppress coughing (Calesnick & Vernick, 1971) , the first line of defense against inhaled infectious agents is typically ascribed to mucociliary clearance. The large airways are lined with ciliated and mucus-producing airway epithelial cells. Cilia beat in a coordinated manner to propel mucus containing trapped particles out of the lung to the oropharynx. Such clearance is not passive as increases in cilia motion are regulated by the action of cyclic nucleotides localized to the ciliary axoneme (Wyatt, Forget, & Sisson, 2003) . Heavy alcohol consumption uncouples this cyclic nucleotide pathway in cilia preventing any increase in cilia beat frequency (Wyatt & Sisson, 2001) . If the heavy drinker also smokes cigarettes, which occurs frequently (DiFranza & Guerrera, 1990) , the cilia may be actively slowed through the action of Protein Kinase C epsilon (Wyatt et al., 2012) , an enzyme upregulated in the airway ciliated cells of older persons (Bailey, Kharbanda, Katafiasz, Sisson, & Wyatt, 2018) .

animal models of cigarette smoke and alcohol co-exposure . It is not known how heavy alcohol intake affects mucus quantity or quality in the lung. However, duodenal goblet cell hyperplasia has been reported in those with AUDs (Lev, Thomas, Parl, & Pitchumoni, 1980) , making it possible that pulmonary goblet cells are also affected. Combined with the co-morbidity of cigarette smoking, AUDs would very likely result in compromised host mechanical clearance under conditions of SARS-CoV-2 exposure, particularly in older individuals.

J o u r n a l P r e -p r o o f If a virus evades mucociliary clearance, the next layer of pulmonary defense is antimicrobial peptides. The human cathelicidin, LL-37, is produced by epithelial cells and neutrophils in a vitamin D-dependent manner. It has been shown to provide protection against influenza A (Tripathi et al., 2013) . Recently, it has been speculated to play an important anti-microbial role against SARS-CoV-2 as vitamin D deficiency is a putative risk factor for COVID-19 (Crane-Godreau, Clem, Payne, & Fiering, 2020; Grant et al., 2020; Panfili et al., 2020) . In vitro, human airway epithelial cells have been shown to produce lower levels of LL-37 after alcohol exposure in response to CYP2E1generated reactive oxygen species (ROS) production, impacting vitamin D metabolism (Ogunsakin, Sriyotha, Burns, Hottor, & McCaskill, 2019) . This lower airway level of LL-37 has the potential to impair the innate immune response to viruses such as COVID-

Once the viral particles have passed through the airways without being cleared, they enter the alveolus. The alveolus is the site where pneumonia and ARDS develop. When the viral particles enter the airways and alveolae, they are met by surfactants. The surfactant protein D (SP-D) is known to bind to the Spike protein of SARS-CoV-1 (Leth-Larsen, Zhong, Chow, Holmskov, & Lu, 2007) , the virus that caused the SARS outbreak in 2002. When the Spike protein is bound by SP-D, it is unable to interact with ACE2 to infect cells. Heavy alcohol intake, especially in conjunction with smoking, can lead to protein adduction that alters its function (McCaskill et al., 2011) . When it is adducted, it can also change the inflammatory response of alveolar macrophages (Muna Sapkota, Kharbanda, & Wyatt, 2016) . Furthermore, decreased expression of lung surfactant has been shown in animal models of chronic alcohol (Lazic et al., 2007) . This suggests that (Okba et al., 2020) and, in some cases, elevated IgA was demonstrated in bronchoalveolar lavage fluid (Du et al., 2008; Lu et al., 2010) . Such reports point to examining the sIgA mucosal immunity response in COVID-19 patients (Moreno-Fierros, García-Silva, & Rosales-Mendoza, 2020) . Again, alcohol could have a negative impact on any sIgA response to COVID-19 as individuals with AUD demonstrate decreased production of lung sIgA to some antigens (M. Sapkota et al., 2017) .

SARS-CoV-2 infection often leads to a "cytokine storms" involving the release of proinflammatory cytokines (e.g., TNF-α, IL-6, IL-1, IL-8, and MCP-1). To further complicate matters the COVID-19-mediated cytokine storm is not self-limiting. In fact, macrophagederived "eicosanoid storm", which is characterized by the release of pro-inflammatory bioactive lipid mediators, such as prostaglandins and leukotrienes often follow the initial cytokine storm. This rapid and severe inflammatory condition is thought to contribute to rapid systemic organ failure observed in critically ill COVID-19 patients. In addition, the effects of alcohol upon activation of danger-associated molecular pattern signaling These data suggest that chronic smoldering inflammation caused by chronic alcohol use could exacerbate the acute inflammatory response to viral infection.

Alveolar macrophages play an essential role in defending the lung from viral infection.

Mice that lack alveolar macrophages have more severe hypoxia and respiratory failure in response to influenza viral infection (Schneider et al., 2014) . The role of macrophages in host defense against SARS-CoV2 is ill-defined. The current data suggest that macrophages contribute to systemic hyper-inflammation, also known as macrophage activation syndrome (MAS) or secondary haemophagocytic lymphohistocytosis (sHLH) that is seen in COVID-19 subjects. Specifically, post-mortem analyses of hilar and subscapular lymph nodes, as well as spleens from patients who died from COVID-19, demonstrate increased numbers of ACE2-expressing J o u r n a l P r e -p r o o f CD68+CD169+ macrophages in both the lymph nodes and spleen. In addition, SARS-CoV-2 nucleoprotein antigen was detected in the macrophages and was associated with upregulation of IL-6 (Feng et al., 2020) .

Heavy alcohol use significantly reduces lung macrophage cytokine production (Standiford & Danforth, 1997) and profoundly affects alveolar macrophage function (Mehta, Guidot, & Weber, 2012; Rimland & Hand, 1980) . Those with heavy alcohol use are unable to efficiently phagocytose infectious particles. This is because alcohol decreases glutathione availability in the lung (Brown, Harris, Ping, & Gauthier, 2004) , which leads to increased oxidative stress (Liang, Harris, & Brown, 2014) and PPAR activation (Samantha M Yeligar, Mehta, Harris, Brown, & Hart, 2016) . Alcohol further impairs macrophage function following engulfment, as antigen presentation, as well as lymphocyte numbers are reduced by alcohol (Molina, Happel, Zhang, Kolls, & Nelson, 2010) . In comparison, circulating monocytes from alcohol abusing subjects express TNFα receptors and spontaneously produce TNFα (Gobejishvili et al., 2006) . In addition, alcohol-associated monocytes stimulated by LPS release even higher levels of TNFα than monocytes from healthy subjects. Alcohol using patients also exhibit elevated systemic levels of other cytokines (e.g., IL-6, IL-8, and IL-18) and chemokines produced by circulating monocytes and liver macrophages (Afford et al., 1998; Fisher, Neil, Williams, & Adams, 1999) .

Collectively this suggests that alcohol use not only impairs the pulmonary macrophage response to SARS-CoV2 by inhibiting cytokine production, viral phagocytosis, and J o u r n a l P r e -p r o o f antigen presentation, it may also significantly contribute to MAS by increase the inflammatory capacity of circulating and liver macrophages.

Neutrophils are one of the first cells recruited to the lungs in response to infection, including viral infection (Galani & Andreakos, 2015) . Specifically, SARS-CoV2, as well as other pandemic viruses, including influenza H1N1, SARS-CoV, and Middle East respiratory syndrome (MERS) coronavirus, are associated with neutrophilic infiltration at sites of infection and development of ARDS (Dandekar & Perlman, 2005) . Alcohol has a direct toxicity on the bone marrow to impair the production of neutrophils (Perlino & Rimland, 1985) . In fact, alcohol users with severe bacterial infection often present with granulocytopenia (Perlino & Rimland, 1985) . Apart from diminished numbers of neutrophils, alcohol use also results in profound defects in neutrophil recruitment to sites of inflammation or infection, phagocytic activity, and activity of both superoxide and elastase (Stoltz et al., 1999) . Thus, in chronic heavy alcohol use, neutrophils are slow to be recruited and neutrophilic inflammation is slow to resolve in bacterial lung infections (Molina et al., 2010) .

Interestingly, it has been shown that sera from patients with COVID-19 have elevated levels of specific markers of neutrophil extracellular traps (NETs; i.e., cell-free DNA, myeloperoxidase-DNA, and citrullinated histone H3). This may be clinically important as both cell-free DNA and myeloperoxidase-DNA levels were higher in hospitalized patients receiving mechanical ventilation as compared with hospitalized patients breathing room air (Zuo et al., 2020) . Similar trends are seen in patients with influenza A J o u r n a l P r e -p r o o f infection, as high levels of NETs predict a poor prognosis (Zhu et al., 2018) .

Additionally, sera from individuals with COVID-19 triggered NET release from control neutrophils in vitro. Recently, alcohol has also been shown to impair the production of NET, as well as NET-mediated killing of both Gram-negative and Gram-positive bacterial pathogens (Jin, Batra, & Jeyaseelan, 2017) , suggesting that alcohol may be protective, at least in regard to COVID-19-mediated NET release and NETosis. Similar results have been seen in influenza-infected mice, as inhibition of NETosis leads to protection from lethal infection. The benefits of blocking or reducing neutrophils in alcohol consuming individuals, however, may be limited as removal of neutrophils from influenza-infected mice led to higher viral titers and lethality (Meyerholz et al., 2008) .

The alveolar barrier prevents edema in the alveoli by restricting the diffusion of large solutes and facilitating gas exchange (Burnham, Halkar, Burks, & Moss, 2009 ). Chronic alcohol ingestion increases the alveolar barrier permeability. Tight junctions are responsible for the barrier and regulate the diffusion of solutes between cells (Zhang, Li, Young, & Caplan, 2006) . Alcohol deteriorates the proteins occluding and zonula occludins 1 (ZO-1), which are integral for tight junctions (Zhang et al., 2006) . When occludin and ZO-1 deteriorate, this deterioation disrupts the tight junction's integrity and allows it to become leakier.

An increase in permeability in the alveoli barrier leads to higher chances of acute lung injury (ACI). A leakier tight junction from alcohol abuse increases water, sodium, and protein levels in the alveolar space (Zhang et al., 2006) . Zinc deficiency in response to J o u r n a l P r e -p r o o f chronic alcohol consumption has been associated with loss of barrier function (Skalny, Skalnaya, Grabeklis, Skalnaya, & Tinkov, 2018) . This causes a higher likelihood of an edematous injury. Patients with ACI or increased water in their lungs face higher chances of acquiring ARDS, which is more severe and can be fatal (Zhang et al., 2006) .

Pulmonary capillary leak in response to COVID-19 infection has also been reported (Bahloul et al., 2020) . Again, zinc status in the lung has been suggested to be important in the maintenance of capillary integrity further underscoring the importance of understanding the impact of alcohol on zinc utilization in lung (Skalny et al., 2020) .

The most severe form of COVID-19 infection results in acute respiratory distress syndrome (ARDS). ARDS is characterized by severe hypoxemia and bilateral diffuse infiltrates on chest roenterogram. Most patients with ARDS require high levels of oxygen or mechanical ventilation. A clear disconnect exists between an early report of severe COVID-19 and ARDS which failed to find an alcohol use association , and the established risk factor of chronic, heavy alcohol use in developing ARDS (Inciardi et al., 2020) . Heavy alcohol use also predisposes those with ARDS to develop multi-system organ failure (Wilke, Kaiser, Ferency, & Maisch, 1996) .

Alcohol increases the mortality and severity of ARDS. Alcohol abuse alters the oxidative stress response and causes the lung to be more susceptible to edematous stress by increasing the alveolar barrier permeability (Esper, Burnham, & Moss, 2006) . By decreasing glutathione (GSH), it impairs the immune response of the lungs. With higher oxidative stress, GSH levels are lower, and oxygen radical levels increase. Alveolar macrophage phagocytosis is hindered due to the increase in free oxygen radicals, and the cell cannot rid themselves of the toxic oxidants (Brown et al., 2004) . Severity and mortality of ARDS increase when alcohol has increased alveolar barrier permeability and lowered GSH levels.

Chronic heavy alcohol use predisposes the lung to these changes by depleting GSH stores (Guidot & Roman, 2002) . GSH is an antioxidant that detoxifies oxidant radicals and protects from oxidant injury (Rahman & MacNee, 2000) . Alcohol is metabolized through the cytochrome p450 system. Acetaldehyde is the major by-product, which induces oxygen radical generation and lipid peroxidation (Brown et al., 2004) . Increased oxygen radicals and lipid peroxidation leads to a decrease in GSH concentration.

Without high GSH levels, the lungs are more susceptible to oxidative stress because they cannot control the detoxification and excretion of toxic oxidants, increasing the likelihood of ARDS (Brown et al., 2004) .

An early meta-analysis of individual reports reveals that severe COVID-19 is associated with COPD (Lippi & Henry, 2020) . In fact, COPD is the single greatest predictor of comorbidity for severe COVID-19 leading to ICU admission (Jain & Yuan, 2020) .

Cigarette smoking is an established cause of COPD and one putative mechanism for increased COVID-19 risk is the smoking-induced upregulation of ACE2 in lung (Brake et al., 2020) . However, alcohol use is prevalent in smokers and alcohol itself has been shown to be an independent risk factor for COPD (Nihlen, Greiff, Nyberg, Persson, & Andersson, 2005; Siu, Udaltsova, Iribarren, & Klatsky, 2010; Tabak et al., 2001) .

Studies examining alcohol or its metabolites on ACE2 have yet to be reported.

Unusual vasculature endothelial pathologies are being observed with COVID-19 (Ackermann et al., 2020) . It is not yet clear whether pulmonary arterial hypertension is a risk factor for severe COVID-19 (Farha, 2020) although management of PAH in the context of coronavirus infection is a concern (Ryan et al., 2020) . As with several chronic disease states, excessive alcohol consumption is associated with hypertension (Sterling et al., 2020) . The intersection of alcohol, COVID-19 and pulmonary hypertension remains to be explored.

High risk alcohol misuse is an established problem in the HIV population (Justice et al., 2006; Lewden et al., 2005) . Such alcohol misuse is known to be associated with poor outcomes related to lung infections in HIV patients (Jolley, Alkhafaf, Hough, & Welsh, 2016) . Recent studies implicate the effect of alcohol on altering gut microbiota as a mechanism for this HIV-associated susceptibility to lung infection (Samuelson et al., 2019) . Not surprisingly, a recent meta-analysis showed that existing J o u r n a l P r e -p r o o f immunosuppression is associated with a 3.3-fold increased risk of severe COVID-19 disease .

Alcohol affects nearly every cell in the lung. Most of these changes potentially put those that drink heavily at higher risk for COVID-19 infection, and more severe pneumonia or ARDS. More research is needed to help us understand how to better treat those with alcohol use disorders with COVID-19.

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis

Epidemic of COVID-19 in China and associated Psychological Problems

Loneliness and alcoholism: a study of three groups of male alcoholics

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection

Oxidative stress associated with aging activates protein kinase Cepsilon, leading to cilia slowing

Covid-19 in critically ill patients in the Seattle region-case series

The breathalyzer and its applications. Medicine, Science and the Law

Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)

Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability?

The effects of alcohol abuse on pulmonary alveolar-capillary barrier function in humans

Antitussive activity of ethanol

Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37

Influence of alcohol on prognosis of pneumonia in Cook County Hospital: a statistical report

Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease

Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37

Immunopathogenesis of coronavirus infections: implications for SARS

Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia

New Methanol Poisoning Outbreaks in Iran Following COVID-19 Pandemic

Alcoholism and smoking

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection

The effect of alcohol abuse on ARDS and multiple organ dysfunction

COVID-19 and pulmonary hypertension

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes

High alcohol intake as a risk and prognostic factor for community-acquired pneumonia

Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease

Neutrophils in viral infections: current concepts and caveats

Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis

Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-κB activity and TNF expression: relevance to alcoholic liver disease

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region

Heavy alcohol use as a risk factor for severe outcomes among adults hospitalized with laboratory-confirmed influenza

Chronic ethanol ingestion increases susceptibility to acute lung injury: role of oxidative stress and tissue remodeling

Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain, behavior, and immunity

Alcohol-dependent pulmonary inflammation: A role for HMGB-1

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis

Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice

Diminished neutrophil extracellular trap (NET) formation is a novel innate immune deficiency induced by acute ethanol exposure in polymicrobial sepsis, which can be rescued by CXCL1

Presence of an alcohol use disorder is associated with greater pneumonia severity in hospitalized HIV-infected patients

Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies

Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia

The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages

Pathological and Histomorphometric Study of the Effects of Alcohol on the Human Duodenum

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

Alcohol induced mitochondrial oxidative stress and alveolar macrophage dysfunction

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)

Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke

Alcohol abuse, the alveolar macrophage and pneumonia. The American journal of the medical sciences

Chronic alcohol consumption increases the severity of murine influenza virus infections

Alcohol research & health : the journal of the National Institute on

Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity

Sharing alcoholic drinks and a COVID-19 outbreak

Total US All Outlets Combined including Convenience and Liquor Stares

Alcohol-induced upper airway symptoms: prevalence and co-morbidity

Alveolar macrophage inflammatory mediator expression is elevated in the setting of

Diallyl disulfide inhibits ethanol-induced pulmonary cell vitamin D and antimicrobial peptide cathelicidin depletion

Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients

Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology

Possible role of vitamin D in Covid-19 infection in pediatric population

Alcoholism, leukopenia, and pneumococcal sepsis

Oxidative stress and regulation of glutathione in lung inflammation

Alcohol use in times of the COVID 19: Implications for monitoring and policy

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

The effect of ethanol on adherence and phagocytosis by rabbit alveolar macrophages

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic

The impact of alcohol-related diagnoses on pneumonia outcomes

Alcohol consumption increases susceptibility to pneumococcal pneumonia in a humanized murine HIV model mediated by intestinal dysbiosis

Malondialdehyde-Acetaldehyde (MAA) Protein Adducts Are Found Exclusively in the Lungs of Smokers with Alcohol Use Disorders and Are Associated with Systemic Anti-MAA Antibodies

Malondialdehyde-Acetaldehyde-Adducted Surfactant Protein Alters Macrophage Functions Through Scavenger Receptor A. Alcoholism

Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection

Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States

Alcohol and lung airways function

Zinc and respiratory tract infections: Perspectives for COVID-19

Zinc deficiency as a mediator of toxic effects of alcohol abuse

Ethanol feeding inhibits proinflammatory cytokine expression from murine alveolar macrophages ex vivo

Associations between medical conditions and alcohol consumption levels in an adult primary care population

Ethanol suppression of the functional state of polymorphonuclear leukocytes obtained from uninfected and simian immunodeficiency virus infected rhesus macaques

Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries

Are patients with alcohol use disorders at increased risk for Covid-19 infection?

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins

Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China

Alcohol and myocarditis

What you need to know

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Alcohol potentiates RSV-mediated injury to ciliated airway epithelium

Ethanol stimulates ciliary beating by dual cyclic nucleotide kinase activation in bovine bronchial epithelial cells

Chronic ethanol downregulates PKA activation and ciliary beating in bovine bronchial epithelial cells

Co-exposure to cigarette smoke and alcohol decreases airway epithelial cell cilia beating in a protein kinase Cε-dependent manner

Alcohol and lung injury and immunity

Peroxisome Proliferator-Activated Receptor γ Regulates Chronic Alcohol-Induced Alveolar Macrophage Dysfunction

Alcohol and lung derangements: An overview

AMP-activated protein kinase regulates the assembly of epithelial tight junctions

High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection

Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19

The Authors wish to acknowledge Madyson Anglim for her contributions and thank Ms.Lisa Chudomelka for expert editorial assistance in the preparation of this manuscript.

This work was supported by the Department of Veterans Affairs (I01BX003635 to TAW, and I01BX005413 to TAW and KLB) and the National Institutes of Health (R01AG053553 to KLB and R00AA026336 to DRS). TAW is the recipient of a Research Career Scientist Award (IK6 BX003781) from the Department of Veterans Affairs.J o u r n a l P r e -p r o o f